Literature DB >> 6278598

[Evaluation of protein-losing enteropathy in the cirrhotic patient by assessing the intestinal clearance of alpha 1 antitrypsin (author's transl)].

J F Bretagne, P Lemee, E Esvant, J Gastard.   

Abstract

The purpose of this study was to evaluate protein-losing enteropathy in cirrhotic patients by assaying the intestinal clearance of alpha 1 antitrypsin (C alpha 1), 28 patients were divided into 5 groups: group A = 4 controls, group B = 6 patients with peptic ulcer, group C = 5 cirrhotic patients without esophageal varices (EV), group D = 6 cirrhotic patients with EV but without ascites, group E = 7 cirrhotic patients with EV and ascites. A significant increase in C alpha 1 was found only in groups D and E. The C 1 level was equal to the mean level found in controls multiplied by 2.5 and added to 2 standard deviations. Increases in C alpha 1 levels were not statistically significant when ascites or gastrointestinal involvement were present. C alpha 1 was significantly correlated to the size of EV (p greater than 0.05) and with the Child ratio (p greater than 0.01). No significant correlation was found between C alpha 1 and serum albumin or prothrombin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278598

Source DB:  PubMed          Journal:  Sem Hop


  1 in total

1.  Reassessment of faecal alpha-1-antitrypsin excretion for use as screening test for intestinal protein loss.

Authors:  E M Quigley; I N Ross; M R Haeney; I B Holbrook; M N Marsh
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.